Pro-inflammatory cytokine-mediated anemia: Regarding molecular mechanisms of erythropoiesis

Mediators of Inflammation

Volumn 2009, Issue , 2009, Pages

  Diederich, M ^a   Morceau, F ^a   Dicato, M ^a  

^a Fondation de Recherche Cancer et Sang   (Luxembourg)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; GAMMA INTERFERON; GROWTH FACTOR; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; STEM CELL FACTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; AUTACOID; TNFSF10 PROTEIN, HUMAN;

ANEMIA; APOPTOSIS; CANCER PATIENT; CELL DIFFERENTIATION; CELL EXPANSION; CELL PROLIFERATION; CYTOKINE PRODUCTION; ERYTHROID CELL; ERYTHROPOIESIS; GENE EXPRESSION; HEMATOPOIETIC STEM CELL; HUMAN; INFLAMMATION; MEDIATOR; MICROARRAY ANALYSIS; MOLECULAR GENETICS; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; NEOPLASM; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; BIOLOGICAL MODEL; BLOOD; DRUG EFFECT; IN VITRO STUDY; PHYSIOLOGY;

ANEMIA; APOPTOSIS; CYTOKINES; ERYTHROPOIESIS; ERYTHROPOIETIN; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; INTERFERON-GAMMA; MODELS, BIOLOGICAL; NEOPLASMS; OXIDATIVE STRESS; SIGNAL TRANSDUCTION; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77952559404     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2009/405016     Document Type: Review

References (135)

1. Stasi R., Abriani L., Beccaglia P., Terzoli E., Amadori S., Cancer-related fatigue: evolving concepts in evaluation and treatment Cancer 2003 98 9 1786 1801
2. Caro J. J., Salas M., Ward A., Goss G., Anemia as an independent prognostic factor for survival in patients with cancer: a systematic, quantitative review Cancer 2001 91 12 2214 2221
3. Knight K., Wade S., Balducci L., Prevalence and outcomes of anemia in cancer: a systematic review of the literature American Journal of Medicine 2004 116 7, supplement 1 11 26 (Pubitemid 38429897)
4. Tas F., Eralp Y., Basaran M., Anemia in oncology practice: relation to diseases and their therapies American Journal of Clinical Oncology 2002 25 4 371 379
5. Groopman J. E., Itri L. M., Chemotherapy-induced anemia in adults: incidence and treatment Journal of the National Cancer Institute 1999 91 19 1616 1634
6. Glaser C. M., Millesi W., Kornek G. V., Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynx International Journal of Radiation Oncology 2001 50 3 705 715 (Pubitemid 32519598)
7. Henke M., Laszig R., Rube C., Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial The Lancet 2003 362 9392 1255 1260
8. Leyland-Jones B., Breast cancer trial with erythropoietin terminated unexpectedly Lancet Oncology 2003 4 8 459 460 (Pubitemid 37009952)
9. Winterbourn C. C., Oxidative denaturation in congenital hemolytic anemias: the unstable hemoglobins Seminars in Hematology 1990 27 1 41 50
10. Johnson R. M., Goyette G. Jr., Ravindranath Y., Ho Y.-S., Hemoglobin autoxidation and regulation of endogenous H 2 O 2 levels in erythrocytes Free Radical Biology and Medicine 2005 39 11 1407 1417
11. Friedman J. S., Rebel V. I., Derby R., Absence of mitochondrial superoxide dismutase results in a murine hemolytic anemia responsive to therapy with a catalytic antioxidant Journal of Experimental Medicine 2001 193 8 925 934
12. Spivak J. L., The anaemia of cancer: death by a thousand cuts Nature Reviews Cancer 2005 5 7 543 555
13. Blick M., Sherwin S. A., Rosenblum M., Gutterman J., Phase I study of recombinant tumor necrosis factor in cancer patients Cancer Research 1987 47 11 2986 2989
14. Dai C.-H., Price J. O., Brunner T., Krantz S. B., Fas ligand is present in human erythroid colony-forming cells and interacts with Fas induced by interferon to produce erythroid cell apoptosis Blood 1998 91 4 1235 1242
15. Johnson R. A., Waddelow T. A., Caro J., Oliff A., Roodman G. D., Chronic exposure to tumor necrosis factor in vivo preferentially inhibits erythropoiesis in nude mice Blood 1989 74 1 130 138
16. Means R. T. Jr., Dessypris E. N., Krantz S. B., Inhibition of human erythroid colony-forming units by interleukin-1 is mediated by gamma interferon Journal of Cellular Physiology 1992 150 1 59 64
17. Moldawer L. L., Marano M. A., Wei H., Cachectin/tumor necrosis factor- alters red blood cell kinetics and induces anemia in vivo FASEB Journal 1989 3 5 1637 1643
18. Zamai L., Secchiero P., Pierpaoli S., TNF-related apoptosis-inducing ligand (TRAIL) as a negative regulator of normal human erythropoiesis Blood 2000 95 12 3716 3724
19. Ek T., Mellander L., Abrahamsson J., Interferon and tumour necrosis factor in relation to anaemia and prognosis in childhood cancer Acta Paediatrica 2005 94 4 435 437
20. Faquin W. C., Schneider T. J., Goldberg M. A., Effect of inflammatory cytokines on hypoxia-induced erythropoietin production Blood 1992 79 8 1987 1994
21. Frede S., Fandrey J., Pagel H., Hellwig T., Jelkmann W., Erythropoietin gene expression is suppressed after lipopolysaccharide or interleukin-1 injections in rats American Journal of Physiology 1997 273 3, part 2 R1067 R1071
22. Vannucchi A. M., Grossi A., Rafanelli D., Statello M., Cinotti S., Rossi-Ferrini P., Inhibition of erythropoietin production in vitro by human interferon gamma British Journal of Haematology 1994 87 1 18 23
23. Buck I., Morceau F., Cristofanon S., Tumor necrosis factor inhibits erythroid differentiation in human erythropoietin-dependent cells involving p38 MAPK pathway, GATA-1 and FOG-1 downregulation and GATA-2 upregulation Biochemical Pharmacology 2008 76 10 1229 1239
24. Buck I., Morceau F., Cristofanon S., Reuter S., Dicato M., Diederich M., The inhibitory effect of the proinflammatory cytokine TNF on erythroid differentiation involves erythroid transcription factor modulation International Journal of Oncology 2009 34 3 853 860
25. Morceau F., Schnekenburger M., Blasius R., Buck I., Dicato M., Diederich M., Tumor necrosis factor alpha inhibits aclacinomycin A-induced erythroid differentiation of K562 cells via GATA-1 Cancer Letters 2006 240 2 203 212
26. Rusten L. S., Jacobsen S. E. W., Tumor necrosis factor (TNF)- directly inhibits human erythropoiesis in vitro: role of p55 and p75 TNF receptors Blood 1995 85 4 989 996
27. Jason J., Archibald L. K., Nwanyanwu O. C., Comparison of serum and cell-specific cytokines in humans Clinical and Diagnostic Laboratory Immunology 2001 8 6 1097 1103
28. Roodman G. D., Bird A., Hutzler D., Montgomery W., Tumor necrosis factor-alpha and hematopoietic progenitors: effects of tumor necrosis factor on the growth of erythroid progenitors CFU-E and BFU-E and the hematopoietic cell lines K562, HL60, and HEL cells Experimental Hematology 1987 15 9 928 935
29. Muta K., Krantz S. B., Bondurant M. C., Dai C.-H., Stem cell factor retards differentiation of normal human erythroid progenitor cells while stimulating proliferation Blood 1995 86 2 572 580
30. von Lindern M., Zauner W., Mellitzer G., The glucocorticoid receptor cooperates with the erythropoietin receptor and c-Kit to enhance and sustain proliferation of erythroid progenitors in vitro Blood 1999 94 2 550 559
31. Livnah O., Stura E. A., Middleton S. A., Johnson D. L., Jolliffe L. K., Wilson I. A., Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation Science 1999 283 5404 987 990
32. Remy I., Wilson I. A., Michnick S. W., Erythropoietin receptor activation by a ligand-induced conformation change Science 1999 283 5404 990 993
33. van den Akker E., van Dijk T., Parren-van Amelsvoort M., Tyrosine kinase receptor RON functions downstream of the erythropoietin receptor to induce expansion of erythroid progenitors Blood 2004 103 12 4457 4465
34. Liu Y., Rohrschneider L. R., The gift of Gab FEBS Letters 2002 515 1-3 1 7
35. Bouscary D., Pene F., Claessens Y.-E., Critical role for PI 3-kinase in the control of erythropoietin-induced erythroid progenitor proliferation Blood 2003 101 9 3436 3443
36. Kashii Y., Uchida M., Kirito K., A member of Forkhead family transcription factor, FKHRL1, is one of the downstream molecules of phosphatidylinositol 3-kinase-Akt activation pathway in erythropoietin signal transduction Blood 2000 96 3 941 949
37. Marinkovic D., Zhang X., Yalcin S., Foxo3 is required for the regulation of oxidative stress in erythropoiesis Journal of Clinical Investigation 2007 117 8 2133 2144
38. Sui X., Krantz S. B., You M., Zhao Z., Synergistic activation of MAP kinase (ERK1/2) by erythropoietin and stem cell factor is essential for expanded erythropoiesis Blood 1998 92 4 1142 1149
39. Carroll M. P., Spivak J. L., McMahon M., Weich N., Rapp U. R., May W. S., Erythropoietin induces Raf-1 activation and Raf-1 is required for erythropoietin-mediated proliferation Journal of Biological Chemistry 1991 266 23 14964 14969
40. Chen C., Sytkowski A. J., Erythropoietin activates two distinct signaling pathways required for the initiation and the elongation of c-myc Journal of Biological Chemistry 2001 276 42 38518 38526
41. Marrero M. B., Venema R. C., Ma H., Ling B. N., Eaton D. C., Erythropoietin receptor-operated Ca 2 + channels: activation by phospholipase C- 1 Kidney International 1998 53 5 1259 1268
42. Mayeux P., Dusanter-Fourt I., Muller O., Erythropoietin induces the association of phosphatidylinositol 3 ′ -kinase with a tyrosine-phosphorylated protein complex containing the erythropoietin receptor European Journal of Biochemistry 1993 216 3 821 828
43. Torti M., Marti K. B., Altschuler D., Yamamoto K., Lapetina E. G., Erythropoietin induces p21ras activation and p120GAP tyrosine phosphorylation in human erythroleukemia cells Journal of Biological Chemistry 1992 267 12 8293 8298
44. Arcasoy M. O., Jiang X., Co-operative signalling mechanisms required for erythroid precursor expansion in response to erythropoietin and stem cell factor British Journal of Haematology 2005 130 1 121 129
45. Jacobs-Helber S. M., Sawyer S. T., Jun N-terminal kinase promotes proliferation of immature erythroid cells and erythropoietin-dependent cell lines Blood 2004 104 3 696 703
46. Kolbus A., Pilat S., Husak Z., Raf-1 antagonizes erythroid differentiation by restraining caspase activation Journal of Experimental Medicine 2002 196 10 1347 1353
47. Foltz I. N., Schrader J. W., Activation of the stress-activated protein kinases by multiple hematopoietic growth factors with the exception of interleukin-4 Blood 1997 89 9 3092 3096
48. Nagata Y., Nishida E., Todokoro K., Activation of JNK signaling pathway by erythropoietin, thrombopoietin, and interleukin-3 Blood 1997 89 8 2664 2669
49. von Lindern M., Parren-van Amelsvoort M., van Dijk T., Protein kinase C controls erythropoietin receptor signaling Journal of Biological Chemistry 2000 275 44 34719 34727
50. Myklebust J. H., Smeland E. B., Josefsen D., Sioud M., Protein kinase C- isoform is involved in erythropoietin-induced erythroid differentiation of CD34+ progenitor cells from human bone marrow Blood 2000 95 2 510 518
51. Uddin S., Ah-Kang J., Ulaszek J., Mahmud D., Wickrema A., Differentiation stage-specific activation of p38 mitogen-activated protein kinase isoforms in primary human erythroid cells Proceedings of the National Academy of Sciences of the United States of America 2004 101 1 147 152
52. Nagata Y., Takahashi N., Davis R. J., Todokoro K., Activation of p38 MAP kinase and JNK but not ERK is required for erythropoietin-induced erythroid differentiation Blood 1998 92 6 1859 1869
53. Socolovsky M., Nam H.-S., Fleming M. D., Haase V. H., Brugnara C., Lodish H. F., Ineffective erythropoiesis in Stat5 a-/-5 b-/-mice due to decreased survival of early erythroblasts Blood 2001 98 12 3261 3273
54. Zeuner A., Eramo A., Testa U., Control of erythroid cell production via caspase-mediated cleavage of transcription factor SCL/Tal-1 Cell Death and Differentiation 2003 10 8 905 913
55. De Maria R., Zeuner A., Eramo A., Negative regulation of erythropoiesis by caspase-mediated cleavage of GATA-1 Nature 1999 401 6752 489 493
56. Prasad K. S. S., Jordan J. E., Koury M. J., Bondurant M. C., Brandt S. J., Erythropoietin stimulates transcription of the TAL1/SCL gene and phosphorylation of its protein products Journal of Biological Chemistry 1995 270 19 11603 11611
57. Tang T., Prasad K. S. S., Koury M. J., Brandt S. J., Mitogen-activated protein kinase mediates erythropoietin-induced phosphorylation of the TAL1/SCL transcription factor in murine proerythroblasts Biochemical Journal 1999 343 3 615 620
58. Ikonomi P., Rivera C. E., Riordan M., Washington G., Schechter A. N., Noguchi C. T., Overexpression of GATA-2 inhibits erythroid and promotes megakaryocyte differentiation Experimental Hematology 2000 28 12 1423 1431
59. Ohneda K., Yamamoto M., Roles of hematopoietic transcription factors GATA-1 and GATA-2 in the development of red blood cell lineage Acta Haematologica 2002 108 4 237 245
60. Chang A. N., Cantor A. B., Fujiwara Y., GATA-factor dependence of the multitype zinc-finger protein FOG-1 for its essential role in megakaryopoiesis Proceedings of the National Academy of Sciences of the United States of America 2002 99 14 9237 9242
61. Tsang A. P., Fujiwara Y., Horn D. B., Orkin S. H., Failure of megakaryopoiesis and arrested erythropoiesis in mice lacking the GATA-1 transcriptional cofactor FOG Genes and Development 1998 12 8 1176 1188
62. Ikonomi P., Noguchi C. T., Miller W., Kassahun H., Hardison R., Schechter A. N., Levels of GATA-1/GATA-2 transcription factors modulate expression of embryonic and fetal hemoglobins Gene 2000 261 2 277 287
63. Tipping A. J., Pina C., Castor A., High GATA-2 expression inhibits human hematopoietic stem and progenitor cell function by effects on cell cycle Blood 2009 113 12 2661 2672
64. Zhao W., Kitidis C., Fleming M. D., Lodish H. F., Ghaffari S., Erythropoietin stimulates phosphorylation and activation of GATA-1 via the PI3-kinase/AKT signaling pathway Blood 2006 107 3 907 915
65. Blobel G. A., Nakajima T., Eckner R., Montminy M., Orkin S. H., CREB-binding protein cooperates with transcription factor GATA-1 and is required for erythroid differentiation Proceedings of the National Academy of Sciences of the United States of America 1998 95 5 2061 2066
66. Boyes J., Byfield P., Nakatani Y., Ogryzko V., Regulation of activity of the transcription factor GATA-1 by acetylation Nature 1998 396 6711 594 598 (Pubitemid 28563723)
67. Hung H.-L., Lau J., Kim A. Y., Weiss M. J., Blobel G. A., CREB-Binding protein acetylates hematopoietic transcription factor GATA- 1 at functionally important sites Molecular and Cellular Biology 1999 19 5 3496 3505
68. Hernandez-Hernandez A., Ray P., Litos G., Acetylation and MAPK phosphorylation cooperate to regulate the degradation of active GATA-1 EMBO Journal 2006 25 14 3264 3274
69. Cantor A. B., Orkin S. H., Transcriptional regulation of erythropoiesis: an affair involving multiple partners Oncogene 2002 21 21 REV. ISS. 2 3368 3376
70. Elagib K. E., Racke F. K., Mogass M., Khetawat R., Delehanty L. L., Goldfarb A. N., RUNX1 and GATA-1 coexpression and cooperation in megakaryocytic differentiation Blood 2003 101 11 4333 4341
71. Ferreira R., Ohneda K., Yamamoto M., Philipsen S., GATA1 function, a paradigm for transcription factors in hematopoiesis Molecular and Cellular Biology 2005 25 4 1215 1227
72. Morceau F., Schnekenburger M., Dicato M., Diederich M., GATA-1: friends, brothers, and coworkers Annals of the New York Academy of Sciences 2004 1030 537 554
73. Shivdasani R. A., Molecular and transcriptional regulation of megakaryocyte differentiation Stem Cells 2001 19 5 397 407
74. Rekhtman N., Radparvar F., Evans T., Skoultchi A. I., Direct interaction of hematopoietic transcription factors PU.1 and GATA- 1: functional antagonism in erythroid cells Genes and Development 1999 13 11 1398 1411
75. Stopka T., Amanatullah D. F., Papetti M., Skoultchi A. I., PU.1 inhibits the erythroid program by binding to GATA-1 on DNA and creating a repressive chromatin structure EMBO Journal 2005 24 21 3712 3723
76. Xiao W., Koizumi K., Nishio M., Tumor necrosis factor- inhibits generation of glycophorin A + cells by CD 34 + cells Experimental Hematology 2002 30 11 1238 1247
77. Papadaki H. A., Kritikos H. D., Valatas V., Boumpas D. T., Eliopoulos G. D., Anemia of chronic disease in rheumatoid arthritis is associated with increased apoptosis of bone marrow erythroid cells: improvement following anti-tumor necrosis factor- antibody therapy Blood 2002 100 2 474 482
78. La Ferla K., Reimann C., Jelkmann W., Hellwig-Brgel T., Inhibition of erythropoietin gene expression signaling involves the transcription factors GATA-2 and NF- B The FASEB Journal 2002 16 13 1811 1813
79. Imagawa S., Nakano Y., Obara N., A GATA-specific inhibitor (K-7174) rescues anemia induced by IL-1, TNF-, or L-NMMA The FASEB Journal 2003 17 12 1742 1744
80. Tsopra O. A., Ziros P. G., Lagadinou E. D., Disease-related anemia in chronic lymphocytic leukemia is not due to intrinsic defects of erythroid precursors: a possible pathogenetic role for tumor necrosis factor-alpha Acta Haematologica 2009 121 4 187 195
81. Liu J.-J., Hou S.-C., Shen C.-K. J., Erythroid gene suppression by NF- B Journal of Biological Chemistry 2003 278 21 19534 19540
82. Morceau F., Aries A., Lahlil R., Evidence for distinct regulation processes in the aclacinomycin-and doxorubicin-mediated differentiation of human erythroleukemic cells Biochemical Pharmacology 1996 51 6 839 845
83. Morceau F., Chnais B., Gillet R., Jardillier J.-C., Jeannesson P., Trentesaux C., Transcriptional and posttranscriptional regulation of erythroid gene expression in anthracycline-induced differentiation of human erythroleukemic cells Cell Growth and Differentiation 1996 7 8 1023 1029
84. Wiley S. R., Schooley K., Smolak P. J., Identification and characterization of a new member of the TNF family that induces apoptosis Immunity 1995 3 6 673 682
85. Snell V., Clodi K., Zhao S., Activity of TNF-related apoptosis-inducing ligand (TRAIL) in haematological malignancies British Journal of Haematology 1997 99 3 618 624
86. Bretz J. D., Rymaszewski M., Arscott P. L., TRAIL death pathway expression and induction in thyroid follicular cells Journal of Biological Chemistry 1999 274 33 23627 23632
87. Herr I., Wilhelm D., Bhler T., Angel P., Debatin K.-M., JNK/SAPK activity is not sufficient for anticancer therapy-induced apoptosis involving CD95-L, TRAIL and TNF-α International Journal of Cancer 1999 80 3 417 424
88. Jeremias I., Herr I., Boehler T., Debatin K.-M., TRAIL/Apo-2-ligand- induced apoptosis in human T cells European Journal of Immunology 1998 28 1 143 152
89. Mariani S. M., Krammer P. H., Differential regulation of TRAIL and CD95 ligand in transformed cells of the T and B lymphocyte lineage European Journal of Immunology 1998 28 3 973 982
90. Walczak H., Degli-Esposti M. A., Johnson R. S., TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL EMBO Journal 1997 16 17 5386 5397
91. Zang D. Y., Goodwin R. G., Loken M. R., Bryant E., Joachim Deeg H., Expression of tumor necrosis factor-related apoptosis-inducing ligand, Apo2L, and its receptors in myelodysplastic syndrome: effects on in vitro hemopoiesis Blood 2001 98 10 3058 3065
92. Campioni D., Secchiero P., Corallini F., Evidence for a role of TNF-related apoptosis-inducing ligand (TRAIL) in the anemia of myelodysplastic syndromes American Journal of Pathology 2005 166 2 557 563
93. Silvestris F., Cafforio P., Tucci M., Dammacco F., Negative regulation of erythroblast maturation by Fas- L + /TRAI L + highly malignant plasma cells: a major pathogenetic mechanism of anemia in multiple myeloma Blood 2002 99 4 1305 1313 (Pubitemid 34547085)
94. Secchiero P., Melloni E., Heikinheimo M., TRAIL regulates normal erythroid maturation through an ERK-dependent pathway Blood 2004 103 2 517 522
95. Kolonics A., Apti A., Jnossy J., Activation of Raf/ERK1/2 MAP kinase pathway is involved in GM-CSF-induced proliferation and survival but not in erythropoietin-induced differentiation of TF-1 cells Cellular Signalling 2001 13 10 743 754
96. Jacobs-Helber S. M., Ryan J. J., Sawyer S. T., JNK and p38 are activated by erythropoietin (EPO) but are not induced in apoptosis following EPO withdrawal in EPO-dependent HCD57 cells Blood 2000 96 3 933 940
97. Miyazaki R., Ogata H., Kobayashi Y., Requirement of thrombopoietin- induced activation of ERK for megakaryocyte differentiation and of p38 erythroid differentiation Annals of Hematology 2001 80 5 284 291
98. Sui X., Krantz S. B., Zhao Z. J., Stem cell factor and erythropoietin inhibit apoptosis of human erythroid progenitor cells through different signalling pathways British Journal of Haematology 2000 110 1 63 70
99. Maciejewski J., Selleri C., Anderson S., Young N. S., Fas antigen expression on CD 34 + human marrow cells is induced by interferon and tumor necrosis factor and potentiates cytokine-mediated hematopoietic suppression in vitro Blood 1995 85 11 3183 3190
100. Zoumbos N. C., Gascon P., Djeu J. Y., Young N. S., Interferon is a mediator of hematopoietic suppression in aplastic anemia in vitro and possibly in vivo Proceedings of the National Academy of Sciences of the United States of America 1985 82 1 188 192
101. Nakao S., Yamaguchi M., Shiobara S., Interferon- gene expression in unstimulated bone marrow mononuclear cells predicts a good response to cyclosporine therapy in aplastic anemia Blood 1992 79 10 2532 2535
102. Nistico A., Young N. S., Gamma-interferon gene expression in the bone marrow of patients with aplastic anemia Annals of Internal Medicine 1994 120 6 463 469
103. Sloand E., Kim S., Maciejewski J. P., Tisdale J., Follmann D., Young N. S., Intracellular interferon- in circulating and marrow T cells detected by flow cytometry and the response to immunosuppressive therapy in patients with aplastic anemia Blood 2002 100 4 1185 1191
104. Viale M., Merli A., Bacigalupo A., Analysis at the clonal level of T-cell phenotype and functions in severe aplastic anemia patients Blood 1991 78 5 1268 1274
105. Zeng W., Chen G., Kajigaya S., Gene expression profiling in CD34 cells to identify differences between aplastic anemia patients and healthy volunteers Blood 2004 103 1 325 332
106. Zeng W., Miyazato A., Chen G., Kajigaya S., Young N. S., Maciejewski J. P., Interferon- -induced gene expression in CD34 cells: identification of pathologic cytokine-specific signature profiles Blood 2006 107 1 167 175
107. Felli N., Pedini F., Zeuner A., Multiple members of the TNF superfamily contribute to IFN- -mediated inhibition of erythropoiesis Journal of Immunology 2005 175 3 1464 1472
108. Bendall L. J., Kortlepel K., Gottlieb D. J., Bone marrow fibroblast exposure to the inflammatory cytokines tumor necrosis factor- and interferon- increases adhesion of acute myeloid leukemia cells and alters the adhesive mechanism Experimental Hematology 1997 25 2 132 139
109. Foley H. A., Ofori-Acquah S. F., Yoshimura A., Critz S., Surendra Baliga B., Pace B. S., Stat3 inhibits -globin gene expression in erythroid cells Journal of Biological Chemistry 2002 277 18 16211 16219
110. Yao X., Kodeboyina S., Liu L., Role of STAT3 and GATA-1 interactions in -globin gene expression Experimental Hematology 2009 37 8 889 900
111. Rabilloud T., Berthier R., Vincon M., Ferbus D., Goubin G., Lawrence J.-J., Early events in erythroid differentiation: accumulation of the acidic peroxidoxin (PRP/TSA/NKEF-B) Biochemical Journal 1995 312 3 699 705
112. Macci A., Madeddu C., Massa D., Hemoglobin levels correlate with interleukin-6 levels in patients with advanced untreated epithelial ovarian cancer: role of inflammation in cancer-related anemia Blood 2005 106 1 362 367
113. Mantovani G., Macci A., Madeddu C., Quantitative evaluation of oxidative stress, chronic inflammatory indices and leptin in cancer patients: correlation with stage and performance status International Journal of Cancer 2002 98 1 84 91
114. Babbar N., Casero R. A. Jr., Tumor necrosis factor- increases reactive oxygen species by inducing spermine oxidase in human lung epithelial cells: a potential mechanism for inflammation-induced carcinogenesis Cancer Research 2006 66 23 11125 11130
115. Tewari R., Sharma V., Koul N., Ebselen abrogates TNF induced pro-inflammatory response in glioblastoma Molecular Oncology 2009 3 1 77 83
116. Sattler M., Winkler T., Verma S., Hematopoietic growth factors signal through the formation of reactive oxygen species Blood 1999 93 9 2928 2935
117. Masutani H., Oxidative stress response and signaling in hematological malignancies and HIV infection International Journal of Hematology 2000 71 1 25 32
118. Smith S. C., Guilbert L. J., Yui J., Baker P. N., Davidge S. T., The role of reactive nitrogen/oxygen intermediates in cytokine-induced trophoblast apoptosis Placenta 1999 20 4 309 315
119. Greenwald R. A., Oxygen radicals, inflammation, and arthritis: pathophysiological considerations and implications for treatment Seminars in Arthritis and Rheumatism 1991 20 4 219 240
120. Chenais B., Andriollo M., Guiraud P., Belhoussine R., Jeannesson P., Oxidative stress involvement in chemically induced differentiation of K562 cells Free Radical Biology and Medicine 2000 28 1 18 27
121. Dallalio G., Means R. T. Jr., Effects of oxidative stress on human erythroid colony formation: modulation by -interferon Journal of Laboratory and Clinical Medicine 2003 141 6 395 400
122. Elorza A., Hyde B., Mikkola H. K., Collins S., Shirihai O. S., UCP2 modulates cell proliferation through the MAPK/ERK pathway during erythropoiesis and has no effect on heme biosynthesis Journal of Biological Chemistry 2008 283 45 30461 30470
123. Shirihai O. S., Gregory T., Yu C., Orkin S. H., Weiss M. J., ABC-me: a novel mitochondrial transporter induced by GATA-1 during erythroid differentiation EMBO Journal 2000 19 11 2492 2502
124. Bai Y., Onuma H., Bai X., Persistent nuclear factor- B activation in Ucp 2-/-mice leads to enhanced nitric oxide and inflammatory cytokine production Journal of Biological Chemistry 2005 280 19 19062 19069
125. Kurzrock R., The role of cytokines in cancer-related fatigue Cancer 2001 92 6, supplement 1684 1688
126. Means R. T. Jr., Pathogenesis of the anemia of chronic disease: a cytokine-mediated anemia Stem Cells 1995 13 1 32 37
127. Miller C. B., Jones R. J., Piantadosi S., Abeloff M. D., Spivak J. L., Decreased erythropoietin response in patients with the anemia of cancer New England Journal of Medicine 1990 322 24 1689 1692
128. Dore L. C., Amigo J. D., Dos Santos C. O., A GATA-1-regulated microRNA locus essential for erythropoiesis Proceedings of the National Academy of Sciences of the United States of America 2008 105 9 3333 3338
129. Felli N., Fontana L., Pelosi E., MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation Proceedings of the National Academy of Sciences of the United States of America 2005 102 50 18081 18086
130. Felli N., Pedini F., Romania P., MicroRNA 223-dependent expression of LMO2 regulates normal erythropoiesis Haematologica 2009 94 4 479 486
131. Fu Y.-F., Du T.-T., Dong M., Mir-144 selectively regulates embryonic -hemoglobin synthesis during primitive erythropoiesis Blood 2009 113 6 1340 1349
132. Masaki S., Ohtsuka R., Abe Y., Muta K., Umemura T., Expression patterns of microRNAs 155 and 451 during normal human erythropoiesis Biochemical and Biophysical Research Communications 2007 364 3 509 514
133. Pase L., Layton J. E., Kloosterman W. P., Carradice D., Waterhouse P. M., Lieschke G. J., miR-451 regulates zebrafish erythroid maturation in vivo via its target gata2 Blood 2009 113 8 1794 1804
134. Tili E., Michaille J.-J., Cimino A., Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF- stimulation and their possible roles in regulating the response to endotoxin shock Journal of Immunology 2007 179 8 5082 5089
135. Wang Q., Huang Z., Xue H., MicroRNA miR-24 inhibits erythropoiesis by targeting activin type I receptor ALK4 Blood 2008 111 2 588 595